Brain-derived neurotrophic factor serum levels in genetically isolated populations: Gender-specific association with anxiety disorder subtypes but not with anxiety levels or Val66Met polymorphism

PeerJ

Volumn 2015, Issue 10, 2015, Pages

  Carlino, Davide ^a   Francavilla, Ruggiero ^a   Baj, Gabriele ^a   Kulak, Karolina ^a   D'Adamo, Pio ^a   Ulivi, Sheila ^b   Cappellani, Stefania ^b   Gasparini, Paolo ^a,b   Tongiorgi, Enrico ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Anxiety; Brain derived neurotrophic factor; Generalized anxiety disorder; Genome wide analysis; Neurotrophins; Serum biomarkers; Sex factors; Social phobia; Specific phobia; Val66Met polymorphism

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; AGED; ANXIETY; ARTICLE; CONTROLLED STUDY; FEMALE; GENERALIZED ANXIETY DISORDER; GENOTYPE; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE ASSESSMENT; PANIC; PHOBIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84946196370     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.1252     Document Type: Article

References (45)

1. Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T. 2007. Mouse and rat BDNF gene structure and expression revisited. Journal of Neuroscience Research 85:525-535 DOI 10.1002/jnr.21139.
2. Aloe L, Bracci-Laudiero L, Alleva E, Lambiase A, Micera A, Tirassa P. 1994. Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 91:10440-10444 DOI 10.1073/pnas.91.22.10440.
3. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, De Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lepine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martinez-Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacin C, Romera B, Taub N, Vollebergh WA. 2004. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. ACTA Psychiatrica Scandinavica. Supplementum 420:55-64 DOI 10.1111/j.1600-0047.2004.00331.x.
4. Aulchenko YS, Ripke S, Isaacs A, Van Duijn CM. 2007. GenABEL: an R library for genome-wide association analysis. Bioinformatics 23:1294-1296 DOI 10.1093/bioinformatics/btm108.
5. Baj G, D'Alessandro V, Musazzi L, Mallei A, Sartori CR, Sciancalepore M, Tardito D, Langone F, Popoli M, Tongiorgi E. 2012. Physical exercise and antidepressants enhance BDNF targeting in hippocampal CA3 dendrites: further evidence of a spatial code for BDNF splice variants. Neuropsychopharmacology 37:1600-1611 DOI 10.1038/npp.2012.5.
6. Bocchio-Chiavetto L, Bagnardi V, Zanardini R, Molteni R, Nielsen MG, Placentino A, Giovannini C, Rillosi L, Ventriglia M, Riva MA, Gennarelli M. 2010. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World Journal of Biological Psychiatry 11:763-773 DOI 10.3109/15622971003611319.
7. Bus BA, Molendijk ML, Penninx BJ, Buitelaar JK, Kenis G, Prickaerts J, Elzinga BM, Voshaar RC. 2011. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 36:228-239 DOI 10.1016/j.psyneuen.2010.07.013.
8. Bus BA, Tendolkar I, Franke B, De Graaf J, Heijer MD, Buitelaar JK, Oude Voshaar RC. 2012. Serum brain-derived neurotrophic factor: determinants and relationship with depressive symptoms in a community population of middle-aged and elderly people. World Journal of Biological Psychiatry 13:39-47 DOI 10.3109/15622975.2010.545187.
9. Carlino D, Baiano M, De Vanna M, Tongiorgi E. 2011. State of art of serum brain-derived neurotrophic factor in schizophrenia. In: Uehara T, ed. Psychiatric disorders-trends and development. InTech. Available at http://www.intechopen.com/books/psychiatric-disorders-trends-and-developments/state-of-art-of-serum-brain-derived-neurotrophic-factor-in-schizophrenia.
10. Catuzzi JE, Beck KD. 2014. Anxiety vulnerability in women: a two-hit hypothesis. Experimental Neurology 259:75-80 DOI 10.1016/j.expneurol.2014.01.023.
11. Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C, McEwen BS, Hempstead BL, Lee FS. 2006. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314:140-143 DOI 10.1126/science.1129663.
12. Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, Pellikka N, Wallaschofski H, Kettunen J, Henneman P, Baumert J, Strachan DP, Fuchsberger C, Vitart V, Wilson JF, Pare G, Naitza S, Rudock ME, Surakka I, De Geus EJ, Alizadeh BZ, Guralnik J, Shuldiner A, Tanaka T, Zee RY, Schnabel RB, Nambi V, Kavousi M, Ripatti S, Nauck M, Smith NL, Smith AV, Sundvall J, Scheet P, Liu Y, Ruokonen A, Rose LM, Larson MG, Hoogeveen RC, Freimer NB, Teumer A, Tracy RP, Launer LJ, Buring JE, Yamamoto JF, FolsomAR, Sijbrands EJ, Pankow J, Elliott P, Keaney JF, Sun W, Sarin AP, Fontes JD, Badola S, Astor BC, Hofman A, Pouta A, Werdan K, Greiser KH, Kuss O, Meyer zu Schwabedissen HE, Thiery J, Jamshidi Y, Nolte IM, Soranzo N, Spector TD, Volzke H, Parker AN, Aspelund T, Bates D, Young L, Tsui K, Siscovick DS, Guo X, Rotter JI, Uda M, Schlessinger D, Rudan I, Hicks AA, Penninx BW, Thorand B, Gieger C, Coresh J, Willemsen G, Harris TB, Uitterlinden AG, Jarvelin MR, Rice K, Radke D, Salomaa V, Willems van Dijk K, Boerwinkle E, Vasan RS, Ferrucci L, Gibson QD, Bandinelli S, Snieder H, Boomsma DI, Xiao X, Campbell H, Hayward C, Pramstaller PP, Van Duijn CM, Peltonen L, Psaty BM, Gudnason V, Ridker PM, Homuth G, Koenig W, Ballantyne CM, Witteman JC, Benjamin EJ, Perola M, Chasman DI. 2011. Meta-analysis of genome-wide association studies in >80, 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 123:731-738 DOI 10.1161/CIRCULATIONAHA.110.948570.
13. Duman RS, Monteggia LM. 2006. A neurotrophic model for stress-related mood disorders. Biological Psychiatry 59:1116-1127 DOI 10.1016/j.biopsych.2006.02.013.
14. Elfving B, Plougmann PH, Wegener G. 2010. Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: pitfalls and solutions. Journal of Neuroscience Methods 187:73-77 DOI 10.1016/j.jneumeth.2009.12.017.
15. Esko T, Mezzavilla M, Nelis M, Borel C, Debniak T, Jakkula E, Julia A, Karachanak S, Khrunin A, Kisfali P, Krulisova V, Ausrele Kucinskiene Z, RehnstromK, Traglia M, Nikitina-Zake L, Zimprich F, Antonarakis SE, Estivill X, Glavac D, Gut I, Klovins J, Krawczak M, Kucinskas V, Lathrop M, Macek M, Marsal S, Meitinger T, Melegh B, Limborska S, Lubinski J, Paolotie A, Schreiber S, Toncheva D, Toniolo D, Wichmann HE, Zimprich A, Metspalu M, Gasparini P, Metspalu A, D'Adamo P. 2013. Genetic characterization of northeastern Italian population isolates in the context of broader European genetic diversity. European Journal of Human Genetics 21:659-665 DOI 10.1038/ejhg.2012.229.
16. Govindarajan A, Rao BS, Nair D, Trinh M, Mawjee N, Tonegawa S, Chattarji S. 2006. Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proceedings of the National Academy of Sciences of the United States of America 103:13208-13213 DOI 10.1073/pnas.0605180103.
17. Hashimoto K. 2010. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry and Clinical Neurosciences 64:341-357 DOI 10.1111/j.1440-1819.2010.02113.x.
18. Jockers-Scherubl MC, Zubraegel D, Baer T, Linden M, Danker-Hopfe H, Schulte-Herbruggen O, Neu P, Hellweg R. 2007. Nerve growth factor serum concentrations rise after successful cognitive-behavioural therapy of generalized anxiety disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31:200-204 DOI 10.1016/j.pnpbp.2006.09.006.
19. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G. 2005. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biological Psychiatry 57:1068-1072 DOI 10.1016/j.biopsych.2005.01.008.
20. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. 2005a. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62:593-602 DOI 10.1001/archpsyc.62.6.593.
21. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. 2005b. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62:617-627 DOI 10.1001/archpsyc.62.6.617.
22. Kobayashi K, Shimizu E, Hashimoto K, Mitsumori M, Koike K, Okamura N, Koizumi H, Ohgake S, Matsuzawa D, Zhang L, Nakazato M, Iyo M. 2005. Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy. Progress in Neuro-Psychopharmacology and Biological Psychiatry 29:658-663 DOI 10.1016/j.pnpbp.2005.04.010.
23. Koponen E, Voikar V, Riekki R, Saarelainen T, Rauramaa T, Rauvala H, Taira T, Castren E. 2004. Transgenic mice overexpressing the full-length neurotrophin receptor trkB exhibit increased activation of the trkB-PLCgamma pathway, reduced anxiety, and facilitated learning. Molecular and Cellular Neuroscience 26:166-181 DOI 10.1016/j.mcn.2004.01.006.
24. Lang UE, Hellweg R, Gallinat J. 2004. BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology 29:795-798 DOI 10.1038/sj.npp.1300382.
25. Lee HY, Kim YK. 2008. Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology 57:194-199 DOI 10.1159/000149817.
26. Leray E, Camara A, Drapier D, Riou F, Bougeant N, Pelissolo A, Lloyd KR, Bellamy V, Roelandt JL, Millet B. 2011. Prevalence, characteristics and comorbidities of anxiety disorders in France: results from the "Mental Health in General Population" survey (MHGP). European Psychiatry 26:339-345 DOI 10.1016/j.eurpsy.2009.12.001.
27. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, Virchow JC. 2005. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiology of Aging 26:115-123 DOI 10.1016/j.neurobiolaging.2004.03.002.
28. Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Kenis G, Prickaerts J, Voshaar RC, Elzinga BM. 2011. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Molecular Psychiatry 16:1088-1095 DOI 10.1038/mp.2010.98.
29. Pallavi P, Sagar R, Mehta M, Sharma S, Subramanium A, Shamshi F, Sengupta U, Qadri R, Pandey RM, Mukhopadhyay AK. 2013. Serum neurotrophic factors in adolescent depression: gender difference and correlation with clinical severity. Journal of Affective Disorders 150:415-423 DOI 10.1016/j.jad.2013.04.033.
30. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. 1998. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37:1553-1561 DOI 10.1016/S0028-3908(98)00141-5.
31. Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T. 2007. Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 90:397-406 DOI 10.1016/j.ygeno.2007.05.004.
32. Rasmussen P, Brassard P, Adser H, Pedersen MV, Leick L, Hart E, Secher NH, Pedersen BK, Pilegaard H. 2009. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Experimental Physiology 94:1062-1069 DOI 10.1113/expphysiol.2009.048512.
33. Sen S, Duman R, Sanacora G. 2008. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biological Psychiatry 64:527-532 DOI 10.1016/j.biopsych.2008.05.005.
34. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, Iyo M. 2003. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biological Psychiatry 54:70-75 DOI 10.1016/S0006-3223(03)00181-1.
35. Strohle A, Stoy M, Graetz B, Scheel M, Wittmann A, Gallinat J, Lang UE, Dimeo F, Hellweg R. 2010. Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder. Psychoneuroendocrinology 35:364-368 DOI 10.1016/j.psyneuen.2009.07.013.
36. Terracciano A, Piras MG, Lobina M, Mulas A, Meirelles O, Sutin AR, Chan W, Sanna S, Uda M, Crisponi L, Schlessinger D. 2013. Genetics of serum BDNF: meta-analysis of the Val66Met and genome-wide association study. World Journal of Biological Psychiatry 14:583-589 DOI 10.3109/15622975.2011.616533.
37. Trajkovska V, Marcussen AB, Vinberg M, Hartvig P, Aznar S, Knudsen GM. 2007. Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data. Brain Research Bulletin 73:143-149 DOI 10.1016/j.brainresbull.2007.03.009.
38. Tsai SJ. 2003. Brain-derived neurotrophic factor: a bridge between major depression and Alzheimer's disease? Medical Hypotheses 61:110-113 DOI 10.1016/S0306-9877(03)00141-5.
39. US Census Bureau. 2005. Available at http://www.census.gov/popest/national/asrh/NC-EST2004/NC-EST2004-02.xls.
40. Van Noorden MS, Van Fenema EM, Van der Wee NJ, Van Rood YR, Carlier IV, Zitman FG, Giltay EJ. 2012. Predicting outcomes of mood, anxiety and somatoform disorders: the Leiden routine outcome monitoring study. Journal of Affective Disorders 142:122-131 DOI 10.1016/j.jad.2012.03.051.
41. Webster MJ, Weickert CS, Herman MM, Kleinman JE. 2002. BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. Brain Research. Developmental Brain Research 139:139-150 DOI 10.1016/S0165-3806(02)00540-0.
42. Yang J, Lee SH, Goddard ME, Visscher PM. 2011. GCTA: a tool for genome-wide complex trait analysis. American Journal of Human Genetics 88:76-82 DOI 10.1016/j.ajhg.2010.11.011.
43. Yee BK, Zhu SW, Mohammed AH, Feldon J. 2007. Levels of neurotrophic factors in the hippocampus and amygdala correlate with anxiety-and fear-related behaviour in C57BL6 mice. Journal of Neural Transmission 114:431-444 DOI 10.1007/s00702-006-0548-9.
44. Yu L, Jiang C, Na J, Li N, Diao W, Gu Y, Zhao L, Zou Y, Chen Y, Liu L, Mu H, Liu Y, Yang X, Pan G. 2013. Elevated 12-month and lifetime prevalence and comorbidity rates of mood, anxiety, and alcohol use disorders in chinese men who have sex with men. PLoS ONE 8:e50762 DOI 10.1371/journal.pone.0050762.
45. Ziegenhorn AA, Schulte-Herbruggen O, Danker-Hopfe H, Malbranc M, Hartung HD, Anders D, Lang UE, Steinhagen-Thiessen E, Schaub RT, Hellweg R. 2007. Serum neurotrophins-a study on the time course and influencing factors in a large old age sample. Neurobiology of Aging 28:1436-1445 DOI 10.1016/j.neurobiolaging.2006.06.011.